Cell-based flu shots may be more cost-effective, beneficial for pediatric population
January 28th 2024A new predictive model from Taiwan suggests cell-based quadrivalent flu vaccines may better egg-based options in reducing disease burden and improving the societal costs of the flu season among children and adolescents.